Pathway-Directed High Throughput Drug Screen Identifies PI3K Inhibitors That Synergistically Potentiate Anti-Tumor Activity of HDAC Inhibitors in Mycosis Fungoides and Sezary SyndromeWeiyun Z. Ai, Frank McCormick, Shervin Afghani et al.|Blood|2015Cited by 2
Abstract 798: Pathway-directed high-throughput drug screen identifies PI3K inhibitors that synergistically potentiate antitumor activity of HDAC inhibitors in cutaneous T-cell lymphomaChi-Heng Wu, Weiyun Z. Ai, Chen‐Yen Yang et al.|Cancer Research|2018Cited by 0